gastroenterology

ATAGI recommends Covid mRNA booster for patients taking immunosuppressive therapies

People taking immunosuppressive therapies are now recommended to have a third primary dose of COVID-19 vaccine with an mRNA vaccine. On 8 October the Australian Technical Advisory Group on Immunisation (ATAGI) recommended a booster third dose of vaccine as part of the primary course in individuals who are severely immunocompromised to address the risk of ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic